-
4m 40sPart 2 | Session 7 FINE-HEART: Design & Baseline Characteristics
-
11m 58sPart 2 | Session 8 HFA 24: The RELIEVE-HF Trial: Differential Effects of V-Wave Device
-
15m 26sPart 1 | Session 1 HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie
-
10m 15sPart 1 | Session 2 Late-Breaker Discussion: The TITRATE-HF Study
-
12m 4sPart 1 | Session 3 Late-Breaker Discussion: Insights from the STEP-HFpEF
-
8m 37sPart 1 | Session 4 Late-Breaker Discussion: Findings from PACT-HF
-
2m 45sPart 2 | Session 1 Remote Patient Monitoring for Patients With Heart Failure: TELESAT
-
5m 3sPart 2 | Session 2 Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF
-
7m 19s
-
5m 24sPart 2 | Session 4 Timing of Cardio-Kidney Protection with SGLT2i
-
2m 54s
HFA 24 - Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) joins us in this succinct interview to outline the findings of the RELIEVE-HF trial (NCT03499236).
RELIEVE-HF was designed to evaluate the safety and effectiveness of the V-Wave inter-atrial shunt system to reduce lung congestion in patients with advanced heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure who had been treated with guideline-directed drug and device therapies were enrolled in the trial. Participants were randomized 1:1 to recieve either the V-Wave inter-atrial shunt, or were included in the control arm.
Interview Questions:
- What is the importance of this study?
- Could you tell us more about the V-Wave inter-atrial shunt system?
- What was the patient population and study design?
- What are your key findings?
- What are the key take-home messages for clinicians?
- What further study is still needed, and what are the next steps?
Recorded onsite at HFA 2024, Lisbon.
Support: This is an independent interview conducted by Radcliffe Cardiology.
Editor: Jordan Rance, Mirjam Boros
Video Specialist: Tom Green
Interviewer: Jonathan McKenna
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Association’s annual congress, Heart Failure 2024.
Dive deep into novel data with in-depth and critical discussions led by Late-breaker host Dr Harriette Van Spall and her expert guests.
For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators.
More from this programme
Part 1
Late-breaker Discussions with Dr Van Spall
Part 2
Expert Interviews
Faculty Biographies
Stefan Anker
Professor of Cardiology
Prof Stefan D Anker is a German cardiologist born in Berlin, Germany. He studied medicine at Charité Medical School of Humboldt University Berlin, where he completed his medical degree in 1993. He later pursued research training at the National Heart & Lung Institute, Imperial College London, completing his PhD in 1998. Following his return to Germany, Prof Anker held academic and research positions at Charité Berlin and later at University Medical Center Göttingen before returning to Charité in 2017 to serve as Professor of (Tissue) Homeostasis in Cardiology & Metabolism. His work has taken him across multiple institutions and countries through long-standing international collaborations.
Academic History
Prof Anker began his medical education at Charité Medical School, graduating in 1993. He then continued postgraduate academic training in both Germany and the United Kingdom, completing his PhD at the National Heart & Lung Institute in London…
Comments